Josep Bassaganya-Riera, Landos Biopharma founder
March 1, 2023 07:14 AM EST
Deals
R&D

Ready to turn a new page, Lan­dos Bio­phar­ma of­floads for­mer lead pro­gram to founder

Amber Tong

Ear­li­er this year, au­toim­mune-fo­cused biotech Lan­dos Bio­phar­ma an­nounced that fol­low­ing a re­view of its pipeline, it will con­cen­trate on one of its clin­i­cal pro­grams and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times